References

1. Weinberger DR, Laruelle M: Neurochemical and neuropharmacologic imaging in schizophrenia, in Neuropsychopharmacology: The Fifth Generation of Progress. Edited by Davis KL, Charney D, Coyle JT, Nemeroff C. Philadelphia, PA, Lippincott Williams & Wilkins, 2002, pp 833-855

2. Bertolino A, Weinberger DR: Proton magnetic resonance spectroscopy in schizophrenia. Eur J Radiol 1999; 30(2):132-41

3. Marenco S, Bertolino A, Weinberger DR: MR proton spectroscopy, in Schizophrenia: from neuroimaging to neuroscience, vol 1. Edited by Lawrie SM, Johnstone EC, Weinberger DR. Oxford, UK, Oxford University Press, 2004, pp 73-92

4. Keshavan MS, Stanley JA, Pettegrew JW: Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings—part II. Biol Psychiatry 2000; 48(5):369-80

5. Stanley JA, Pettegrew JW, Keshavan MS: Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings—part I. Biol Psychiatry 2000; 48(5):357-68

6. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT: Multisection proton MR spectroscopic imaging of the brain. Radiology 1993; 188(1):277-82

7. van Der Veen JW, Weinberger DR, Tedeschi G, Frank JA, Duyn JH: Proton MR spectroscopic imaging without water suppression. Radiology 2000; 217(1):296-300

8. Weinberger DR: Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999; 45(4):395-402

9. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE: Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 2001; 50(11):825-44

10. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, Frank JA, Tedeschi G, Weinberger DR: Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996; 153(12):1554-63

11. Bertolino A, Callicott JH, Nawroz S, Mattay VS, Duyn JH, Tedeschi G, Frank JA, Weinberger DR: Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. Neuropsychopharmacology 1998; 18(1):1-9

12. Bertolino A, Kumra S, Callicott JH, Mattay VS, Lestz RM, Jacobsen L, Barnett IS, Duyn JH, Frank JA, Rapoport JL, Weinberger DR: Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1998; 155(10):1376-83

13. Callicott JH, Egan MF, Bertolino A, Mattay VS, Langheim FJ, Frank JA, Weinberger DR: Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biol Psychiatry 1998; 44(10):941-50

14. Callicott JH, Bertolino A, Egan MF, Mattay VS, Langheim FJ, Weinberger DR: Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. Am J Psychiatry 2000; 157(10):1646-51

15. Lewis DA, Lieberman JA: Catching up on schizophrenia: natural history and neurobiology. Neuron 2000; 28(2):325-34

16. Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF, Weinberger DR: The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 2001; 49(1):39-46

17. Bertolino A, Esposito G, Callicott JH, Mattay VS, Van Horn JD, Frank JA, Berman KF, Weinberger DR: Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry 2000; 157(1):26-33

18. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, Goldberg TE, Weinberger DR: Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 2000; 10(11):1078-92

19. Winterer G, Weinberger DR: Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 2004; 27(11):683-90

20. Bertolino A, Breier A, Callicott JH, Adler C, Mattay VS, Shapiro M, Frank JA, Pickar D, Weinberger DR: The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology 2000; 22(2):125-32

21. Bertolino A, Knable MB, Saunders RC, Callicott JH, Kolachana B, Mattay VS, Bachevalier J, Frank JA, Egan M, Weinberger DR: The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry 1999; 45(6):660-7

22. Lipska BK, Jaskiw GE, Weinberger DR: Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 1993; 9(1):67-75

23. Saunders RC, Kolachana BS, Bachevalier J, Weinberger DR: Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature 1998; 393(6681):169-71

24. Lipska BK, Weinberger DR: To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 2000; 23(3):223-39

25. Bertolino A, Roffman JL, Lipska BK, van Gelderen P, Olson A, Weinberger DR: Reduced N-acetylaspartate in prefrontal cortex of adult rats with neonatal hippocampal damage. Cereb Cortex 2002; 12(9):983-90

26. Bertolino A, Saunders RC, Mattay VS, Bachevalier J, Frank JA, Weinberger DR: Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study. Cereb Cortex 1997; 7(8):740-8

27. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR: The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112(2):257-69

28. Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, Kleinman JE, Weinberger DR: Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A 2004; 101(34):12604-9

29. Steele SU, Marenco S, Barnett AS, van der Veen JW, Egan MF, Weinberger DR: GRM3 genotype is associated with reduced N-acetyl aspartate levels in the frontal cortex: A partial replication. Biological Psychiatry 2004; 55:167S-167S

All About Alzheimers

All About Alzheimers

The comprehensive new ebook All About Alzheimers puts everything into perspective. Youll gain insight and awareness into the disease. Learn how to maintain the patients emotional health. Discover tactics you can use to deal with constant life changes. Find out how counselors can help, and when they should intervene. Learn safety precautions that can protect you, your family and your loved one. All About Alzheimers will truly empower you.

Get My Free Ebook


Post a comment